Clean intermittent catheterization in myelomeningocele children less than 3 years old

Area of Science:

• Pediatric Urology
• Nephrology
• Medical Engineering

Background:

• Myelodysplastic conditions often lead to urinary tract complications.
• Inefficient bladder evacuation, reflux, and infections are common in affected children.
• Upper urinary tract changes pose a significant risk.

Purpose of the Study:

• To evaluate the efficacy and safety of clean intermittent catheterization (CIC) in managing urinary issues in myelodysplastic children.
• To assess the impact of CIC on upper urinary tract changes, reflux, and urinary tract infections (UTIs).
• To determine the feasibility and safety of CIC in neonates with myelodysplastic conditions.

Main Methods:

• Clean intermittent catheterization (CIC) was implemented in 34 children with myelodysplastic conditions.
• Patient compliance and any adverse events were meticulously monitored.
• Outcomes including upper tract changes, reflux, UTIs, and bladder evacuation efficiency were assessed.

Main Results:

• Excellent compliance with CIC was observed across the study cohort.
• No serious complications were reported during the use of CIC.
• Significant improvements were noted in upper tract changes and reflux.
• A marked decrease in the incidence of urinary tract infections was achieved.
• CIC demonstrated feasibility and safety in neonates, preserving urinary tract integrity.

Conclusions:

• Clean intermittent catheterization (CIC) is a safe and effective intervention for myelodysplastic children.
• CIC significantly reduces urinary tract infections and improves upper urinary tract status.
• The procedure is feasible and beneficial even in the neonatal period, ensuring long-term urinary tract health.